CP-615,003
Chemical compound / From Wikipedia, the free encyclopedia
CP-615,003 is a drug which acts as a subtype-selective partial agonist at GABAA receptors, and was developed by Pfizer as a potential anxiolytic; however, poor blood–brain barrier penetration make it primarily useful as a research ligand.[1][2]
Quick Facts Identifiers, CAS Number ...
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H24FN3O3 |
Molar mass | 373.428 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Close